Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

The impact of spelling regularity on handwriting production: A coupled fMRI and kinematics study.

Palmis S, Velay JL, Fabiani E, Nazarian B, Anton JL, Habib M, Kandel S, Longcamp M.

Cortex. 2018 Dec 10;113:111-127. doi: 10.1016/j.cortex.2018.11.024. [Epub ahead of print]

PMID:
30640140
2.

Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS).

Fabiani E, Calabrese C, Niscola P, Balleari E, Molteni A, Finelli C, Falconi G, Fenu S, Fianchi L, Criscuolo M, Salvi F, Lavorgna S, Buccisano F, Maurillo L, Lo Coco F, Cilloni D, Voso MT.

Br J Haematol. 2018 Nov 8. doi: 10.1111/bjh.15655. [Epub ahead of print] No abstract available.

PMID:
30407614
3.

Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes.

Falconi G, Fabiani E, Piciocchi A, Criscuolo M, Fianchi L, Lindfors Rossi EL, Finelli C, Cerqui E, Ottone T, Molteni A, Parma M, Santarone S, Candoni A, Sica S, Leone G, Lo-Coco F, Voso MT.

Leukemia. 2019 Mar;33(3):785-790. doi: 10.1038/s41375-018-0284-9. Epub 2018 Oct 5. No abstract available.

PMID:
30291338
4.

Therapy-related myeloid neoplasms: clinical perspectives.

Fianchi L, Criscuolo M, Fabiani E, Falconi G, Maraglino AME, Voso MT, Pagano L.

Onco Targets Ther. 2018 Sep 17;11:5909-5915. doi: 10.2147/OTT.S101333. eCollection 2018. Review.

5.

Epigenome modifiers and metabolic rewiring: New frontiers in therapeutics.

Ferrari A, Longo R, Silva R, Mitro N, Caruso D, De Fabiani E, Crestani M.

Pharmacol Ther. 2019 Jan;193:178-193. doi: 10.1016/j.pharmthera.2018.08.008. Epub 2018 Aug 17. Review.

PMID:
30125527
6.

A bio-guided approach for the development of a chestnut-based proanthocyanidin-enriched nutraceutical with potential anti-gastritis properties.

Sangiovanni E, Piazza S, Vrhovsek U, Fumagalli M, Khalilpour S, Masuero D, Di Lorenzo C, Colombo L, Mattivi F, De Fabiani E, Dell'Agli M.

Pharmacol Res. 2018 Aug;134:145-155. doi: 10.1016/j.phrs.2018.06.016. Epub 2018 Jun 18.

PMID:
29928974
7.

Zc3h10 is a novel mitochondrial regulator.

Audano M, Pedretti S, Cermenati G, Brioschi E, Diaferia GR, Ghisletti S, Cuomo A, Bonaldi T, Salerno F, Mora M, Grigore L, Garlaschelli K, Baragetti A, Bonacina F, Catapano AL, Norata GD, Crestani M, Caruso D, Saez E, De Fabiani E, Mitro N.

EMBO Rep. 2018 Apr;19(4). pii: e45531. doi: 10.15252/embr.201745531. Epub 2018 Mar 5.

PMID:
29507079
8.

Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemia.

Gurnari C, Panetta P, Fabiani E, Nardone AM, Postorivo D, Falconi G, Franceschini L, Rizzo M, Rapisarda VM, De Bellis E, Lo-Coco F, Voso MT.

Mol Clin Oncol. 2018 Mar;8(3):463-465. doi: 10.3892/mco.2017.1543. Epub 2017 Dec 29.

9.

Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia.

Ottone T, Alfonso V, Iaccarino L, Hasan SK, Mancini M, Divona M, Lavorgna S, Cicconi L, Panetta P, Maurillo L, Del Principe MI, Irno Consalvo M, Franceschini L, Angelini DF, Battistini L, Guerrera G, De Bardi M, Fabiani E, Falconi G, Arcese W, Amadori S, Buccisano F, Venditti A, Voso MT, Lo-Coco F.

Am J Hematol. 2018 May;93(5):E120-E123. doi: 10.1002/ajh.25061. Epub 2018 Feb 24. No abstract available.

PMID:
29417611
10.

MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine.

Visani G, Loscocco F, Ruzzo A, Galimberti S, Graziano F, Voso MT, Giacomini E, Finelli C, Ciabatti E, Fabiani E, Barulli S, Volpe A, Magro D, Piccaluga P, Fuligni F, Vignetti M, Fazi P, Piciocchi A, Gabucci E, Rocchi M, Magnani M, Isidori A.

Pharmacogenomics J. 2018 May 22;18(3):444-449. doi: 10.1038/tpj.2017.48. Epub 2017 Dec 5.

PMID:
29205204
11.

The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia.

Fabiani E, Falconi G, Noguera NI, Saulle E, Cicconi L, Divona M, Banella C, Picardi A, Cerio AM, Boe L, Sanchez M, Pelosi E, Testa U, Lo-Coco F, Voso MT.

Oncotarget. 2017 Sep 20;8(48):84074-84085. doi: 10.18632/oncotarget.21101. eCollection 2017 Oct 13.

12.

Gender-related metabolomics and lipidomics: From experimental animal models to clinical evidence.

Audano M, Maldini M, De Fabiani E, Mitro N, Caruso D.

J Proteomics. 2018 Apr 30;178:82-91. doi: 10.1016/j.jprot.2017.11.001. Epub 2017 Nov 6. Review.

PMID:
29122727
13.

HDAC3 is a molecular brake of the metabolic switch supporting white adipose tissue browning.

Ferrari A, Longo R, Fiorino E, Silva R, Mitro N, Cermenati G, Gilardi F, Desvergne B, Andolfo A, Magagnotti C, Caruso D, Fabiani E, Hiebert SW, Crestani M.

Nat Commun. 2017 Jul 21;8(1):93. doi: 10.1038/s41467-017-00182-7.

14.

Clonal evolution in therapy-related neoplasms.

Fabiani E, Falconi G, Fianchi L, Criscuolo M, Ottone T, Cicconi L, Hohaus S, Sica S, Postorino M, Neri A, Lionetti M, Leone G, Lo-Coco F, Voso MT.

Oncotarget. 2017 Feb 14;8(7):12031-12040. doi: 10.18632/oncotarget.14509.

15.

Attenuation of diet-induced obesity and induction of white fat browning with a chemical inhibitor of histone deacetylases.

Ferrari A, Fiorino E, Longo R, Barilla S, Mitro N, Cermenati G, Giudici M, Caruso D, Mai A, Guerrini U, De Fabiani E, Crestani M.

Int J Obes (Lond). 2017 Feb;41(2):289-298. doi: 10.1038/ijo.2016.191. Epub 2016 Oct 28.

PMID:
27795551
16.

Strawberry tannins inhibit IL-8 secretion in a cell model of gastric inflammation.

Fumagalli M, Sangiovanni E, Vrhovsek U, Piazza S, Colombo E, Gasperotti M, Mattivi F, De Fabiani E, Dell'Agli M.

Pharmacol Res. 2016 Sep;111:703-712. doi: 10.1016/j.phrs.2016.07.028. Epub 2016 Jul 27.

PMID:
27473819
17.

A case of SRSF2 mutation in chronic lymphocytic leukemia.

Garza E, Del Poeta G, Martínez-Losada C, Catalano G, Borgia L, Piredda ML, Fabiani E, Gattei V, Lo-Coco F, Noguera NI.

Leuk Res Rep. 2016 Jun 23;6:11-4. doi: 10.1016/j.lrr.2016.03.001. eCollection 2016.

18.

Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.

Falconi G, Fabiani E, Fianchi L, Criscuolo M, Raffaelli CS, Bellesi S, Hohaus S, Voso MT, D'Alò F, Leone G.

Exp Hematol. 2016 Jan;44(1):75-83.e1-4. doi: 10.1016/j.exphem.2015.10.005. Epub 2015 Oct 28.

PMID:
26521017
19.

Molecular adaptation and salt stress response of Halobacterium salinarum cells revealed by neutron spectroscopy.

Vauclare P, Marty V, Fabiani E, Martinez N, Jasnin M, Gabel F, Peters J, Zaccai G, Franzetti B.

Extremophiles. 2015 Nov;19(6):1099-107. doi: 10.1007/s00792-015-0782-x. Epub 2015 Sep 16.

PMID:
26376634
20.

Fanconi anemia gene variants in therapy-related myeloid neoplasms.

Voso MT, Fabiani E, Zang Z, Fianchi L, Falconi G, Padella A, Martini M, Li Zhang S, Santangelo R, Larocca LM, Criscuolo M, La Brocca A, Cutcutache I, Rozen S, Simonetti G, Manfrini M, Martinelli G, Hohaus S, Leone G, Tan P, Tenen DG.

Blood Cancer J. 2015 Jul 3;5:e323. doi: 10.1038/bcj.2015.44. No abstract available.

21.

Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia.

Teofili L, Martini M, Nuzzolo ER, Capodimonti S, Iachininoto MG, Cocomazzi A, Fabiani E, Voso MT, Larocca LM.

Neoplasia. 2015 May;17(5):401-9. doi: 10.1016/j.neo.2015.04.001.

22.

Lack of sterol regulatory element binding factor-1c imposes glial Fatty Acid utilization leading to peripheral neuropathy.

Cermenati G, Audano M, Giatti S, Carozzi V, Porretta-Serapiglia C, Pettinato E, Ferri C, D'Antonio M, De Fabiani E, Crestani M, Scurati S, Saez E, Azcoitia I, Cavaletti G, Garcia-Segura LM, Melcangi RC, Caruso D, Mitro N.

Cell Metab. 2015 Apr 7;21(4):571-83. doi: 10.1016/j.cmet.2015.02.016. Epub 2015 Mar 26.

23.

Olive oil phenolic extract regulates interleukin-8 expression by transcriptional and posttranscriptional mechanisms in Caco-2 cells.

Muto E, Dell'Agli M, Sangiovanni E, Mitro N, Fumagalli M, Crestani M, De Fabiani E, Caruso D.

Mol Nutr Food Res. 2015 Jun;59(6):1217-21. doi: 10.1002/mnfr.201400800. Epub 2015 Apr 27.

PMID:
25708117
24.

Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias.

Fianchi L, Pagano L, Piciocchi A, Candoni A, Gaidano G, Breccia M, Criscuolo M, Specchia G, Maria Pogliani E, Maurillo L, Aloe-Spiriti MA, Mecucci C, Niscola P, Rossetti E, Mansueto G, Rondoni M, Fozza C, Invernizzi R, Spadea A, Fenu S, Buda G, Gobbi M, Fabiani E, Sica S, Hohaus S, Leone G, Voso MT.

Am J Hematol. 2015 May;90(5):E80-5. doi: 10.1002/ajh.23966. Epub 2015 Mar 3.

25.

Energizing Genetics and Epi-genetics: Role in the Regulation of Mitochondrial Function.

Audano M, Ferrari A, Fiorino E, Kuenzl M, Caruso D, Mitro N, Crestani M, De Fabiani E.

Curr Genomics. 2014 Dec;15(6):436-56. doi: 10.2174/138920291506150106151119.

26.

The lipogenic regulator Sterol Regulatory Element Binding Factor-1c is required to maintain peripheral nerve structure and function.

Mitro N, Cermenati G, Audano M, Giatti S, D'Antonio M, Fabiani ED, Crestani M, Saez E, Azcoitia I, Cavaletti G, Garcia-Segura LM, Melcangi RC, Caruso D.

Springerplus. 2015 Jun 12;4(Suppl 1):L45. doi: 10.1186/2193-1801-4-S1-L45. eCollection 2015. No abstract available.

27.

Development of a high-resolution melting curve analysis screening test for SRSF2 splicing factor gene mutations in myelodysplastic syndromes.

Garza E, Fabiani E, Noguera N, Panetta P, Piredda ML, Borgia L, Maurillo L, Catalano G, Voso MT, Lo-Coco F.

J Mol Diagn. 2015 Jan;17(1):85-9. doi: 10.1016/j.jmoldx.2014.08.002. Epub 2014 Oct 24.

PMID:
25445211
28.

Lipids in the nervous system: from biochemistry and molecular biology to patho-physiology.

Cermenati G, Mitro N, Audano M, Melcangi RC, Crestani M, De Fabiani E, Caruso D.

Biochim Biophys Acta. 2015 Jan;1851(1):51-60. doi: 10.1016/j.bbalip.2014.08.011. Epub 2014 Aug 20. Review.

PMID:
25150974
29.

Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy.

Musto P, Simeon V, Guariglia R, Bianchino G, Grieco V, Nozza F, La Rocca F, Marziano G, Lalinga AV, Fabiani E, Voso MT, Scaravaglio P, Mecucci C, D'Arena G.

Onco Targets Ther. 2014 Jun 13;7:1043-50. doi: 10.2147/OTT.S59628. eCollection 2014. Review.

30.

SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.

Fabiani E, Falconi G, Fianchi L, Criscuolo M, Leone G, Voso MT.

Haematologica. 2014 Sep;99(9):e152-3. doi: 10.3324/haematol.2014.108159. Epub 2014 Jun 6. No abstract available.

31.

Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies.

Fabiani E, Falconi G, Fianchi L, Guidi F, Bellesi S, Voso MT, Leone G, D'Alò F.

Exp Hematol. 2014 Sep;42(9):731-3. doi: 10.1016/j.exphem.2014.04.011. Epub 2014 May 4. No abstract available.

PMID:
24796317
32.

Why methylation is not a marker predictive of response to hypomethylating agents.

Voso MT, Santini V, Fabiani E, Fianchi L, Criscuolo M, Falconi G, Guidi F, Hohaus S, Leone G.

Haematologica. 2014 Apr;99(4):613-9. doi: 10.3324/haematol.2013.099549. Review.

33.

Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms.

Criscuolo M, Chiusolo P, Giammarco S, Giachelia M, Fianchi L, Fabiani E, Falconi G, Hohaus S, Sica S, Leone G, Voso MT.

Leuk Lymphoma. 2014 Dec;55(12):2942-4. doi: 10.3109/10428194.2014.903475. Epub 2014 Apr 22. No abstract available.

PMID:
24625325
34.

Neuroactive steroid treatment modulates myelin lipid profile in diabetic peripheral neuropathy.

Mitro N, Cermenati G, Brioschi E, Abbiati F, Audano M, Giatti S, Crestani M, De Fabiani E, Azcoitia I, Garcia-Segura LM, Caruso D, Melcangi RC.

J Steroid Biochem Mol Biol. 2014 Sep;143:115-21. doi: 10.1016/j.jsbmb.2014.02.015. Epub 2014 Mar 4.

PMID:
24607810
35.

The sirtuin class of histone deacetylases: regulation and roles in lipid metabolism.

Fiorino E, Giudici M, Ferrari A, Mitro N, Caruso D, De Fabiani E, Crestani M.

IUBMB Life. 2014 Feb;66(2):89-99. doi: 10.1002/iub.1246. Epub 2014 Feb 3. Review.

36.

LT175 is a novel PPARα/γ ligand with potent insulin-sensitizing effects and reduced adipogenic properties.

Gilardi F, Giudici M, Mitro N, Maschi O, Guerrini U, Rando G, Maggi A, Cermenati G, Laghezza A, Loiodice F, Pochetti G, Lavecchia A, Caruso D, De Fabiani E, Bamberg K, Crestani M.

J Biol Chem. 2014 Mar 7;289(10):6908-20. doi: 10.1074/jbc.M113.506394. Epub 2014 Jan 22.

37.

The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes.

Fabiani E, Fianchi L, Falconi G, Boncompagni R, Criscuolo M, Guidi F, La Brocca A, Hohaus S, Leone G, Voso MT.

Leuk Lymphoma. 2014 Jul;55(7):1538-43. doi: 10.3109/10428194.2013.845885. Epub 2013 Nov 1.

PMID:
24047476
38.

Total thyroidectomy for Graves' disease treatment.

Catania A, Guaitoli E, Carbotta G, Bianchini M, Di Matteo FM, Carbotta S, Nardi M, Fabiani E, Grani G, D'Andrea V, Fumarola A.

Clin Ter. 2013 May-Jun;164(3):193-6. doi: 10.7417/CT.2013.1548.

PMID:
23868618
39.

Neutron scattering: a tool to detect in vivo thermal stress effects at the molecular dynamics level in micro-organisms.

Marty V, Jasnin M, Fabiani E, Vauclare P, Gabel F, Trapp M, Peters J, Zaccai G, Franzetti B.

J R Soc Interface. 2013 Feb 27;10(82):20130003. doi: 10.1098/rsif.2013.0003. Print 2013 May 6.

40.

Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells.

Barbetti V, Gozzini A, Cheloni G, Marzi I, Fabiani E, Santini V, Dello Sbarba P, Rovida E.

Epigenetics. 2013 Feb;8(2):210-9. doi: 10.4161/epi.23538. Epub 2013 Jan 15. Erratum in: Epigenetics. 2013 Dec;8(12):1384.

41.

Linking epigenetics to lipid metabolism: focus on histone deacetylases.

Ferrari A, Fiorino E, Giudici M, Gilardi F, Galmozzi A, Mitro N, Cermenati G, Godio C, Caruso D, De Fabiani E, Crestani M.

Mol Membr Biol. 2012 Nov;29(7):257-66. doi: 10.3109/09687688.2012.729094. Epub 2012 Oct 24. Review.

PMID:
23095054
42.

Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue.

Galmozzi A, Mitro N, Ferrari A, Gers E, Gilardi F, Godio C, Cermenati G, Gualerzi A, Donetti E, Rotili D, Valente S, Guerrini U, Caruso D, Mai A, Saez E, De Fabiani E, Crestani M.

Diabetes. 2013 Mar;62(3):732-42. doi: 10.2337/db12-0548. Epub 2012 Oct 15.

43.

Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases.

Voso MT, Fabiani E, Fianchi L, Falconi G, Criscuolo M, Santangelo R, Chiusolo P, Betti S, D'Alo' F, Hohaus S, De Stefano V, Leone G.

Leukemia. 2013 Apr;27(4):982-5. doi: 10.1038/leu.2012.267. Epub 2012 Sep 11. No abstract available.

PMID:
22964944
44.

Shoulder osteolytic lesion: an unusual presentation of undifferentiated pancreatic carcinoma.

Guarino S, Palermo S, Giusti DM, Greco R, Favoriti P, Fabiani E, Sorrenti S, de Antoni E.

Pancreas. 2012 Jul;41(5):813. doi: 10.1097/MPA.0b013e31823e3dc3. No abstract available.

PMID:
22695094
45.

Similarities and differences between therapy-related and elderly acute myeloid leukemia.

D'Alò F, Fianchi L, Fabiani E, Criscuolo M, Greco M, Guidi F, Pagano L, Leone G, Voso MT.

Mediterr J Hematol Infect Dis. 2011;3(1):e2011052. doi: 10.4084/MJHID.2011.052. Epub 2011 Nov 28.

46.

Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation.

Cermenati G, Abbiati F, Cermenati S, Brioschi E, Volonterio A, Cavaletti G, Saez E, De Fabiani E, Crestani M, Garcia-Segura LM, Melcangi RC, Caruso D, Mitro N.

J Lipid Res. 2012 Feb;53(2):300-10. doi: 10.1194/jlr.M021188. Epub 2011 Dec 7.

47.

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine.

Voso MT, Fabiani E, Piciocchi A, Matteucci C, Brandimarte L, Finelli C, Pogliani E, Angelucci E, Fioritoni G, Musto P, Greco M, Criscuolo M, Fianchi L, Vignetti M, Santini V, Hohaus S, Mecucci C, Leone G.

Leukemia. 2011 Dec;25(12):1910-3. doi: 10.1038/leu.2011.170. Epub 2011 Jul 15. No abstract available.

PMID:
21760590
48.

5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature.

Greco M, Criscuolo M, Fianchi L, Fabiani E, Pagano L, Voso M.

Mediterr J Hematol Infect Dis. 2011;3(1):e2011011. doi: 10.4084/MJHID.2011.011. Epub 2011 Mar 15.

49.

Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia.

Fabiani E, Leone G, Giachelia M, D'alo' F, Greco M, Criscuolo M, Guidi F, Rutella S, Hohaus S, Voso MT.

Leuk Lymphoma. 2010 Dec;51(12):2275-84. doi: 10.3109/10428194.2010.528093. Epub 2010 Nov 15.

PMID:
21077739
50.

The prevalence of celiac disease in Europe: results of a centralized, international mass screening project.

Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, McMillan S, Murray L, Metzger MH, Gasparin M, Bravi E, Mäki M; Coeliac EU Cluster, Project Epidemiology.

Ann Med. 2010 Dec;42(8):587-95. doi: 10.3109/07853890.2010.505931.

PMID:
21070098

Supplemental Content

Loading ...
Support Center